News
You are here: Home » News

Latest News & Updates of Loncom Pharma

2024
DATE
06 - 19
What Is Elagolix Sodium? A New Hope for Endometriosis And Uterine Fibroid Sufferers
In recent years, a new medication called Elagolix Sodium has emerged as a promising treatment for women suffering from endometriosis and uterine fibroids, offering significant relief from these debilitating conditions.Understanding Elagolix SodiumElagolix sodium is an oral medication that works as a
Read More
2024
DATE
06 - 07
Darolutamide: A Promising Advancement in Prostate Cancer Treatment
Darolutamide: A Promising Advancement in Prostate Cancer TreatmentDarolutamide, a next-generation androgen receptor inhibitor, has emerged as a promising therapeutic option for patients with prostate cancer, particularly those with non-metastatic castration-resistant prostate cancer (nmCRPC). This m
Read More
2024
DATE
06 - 06
Elagolix Sodium: A Breakthrough in Endometriosis and Uterine Fibroid Management
lagolix sodium, a novel oral medication, represents a significant advancement in the treatment of endometriosis and uterine fibroids, conditions that affect millions of women worldwide. Endometriosis, characterized by the growth of endometrial-like tissue outside the uterus, causes severe pain and i
Read More
2024
DATE
06 - 04
Silodosin,Elagolix sodium,Daprodustat and Vonprazon Fumarate Gained WC certificate
ShandongLoncom Co., Ltd. is proud to announce that our four products obtained WC certification. The four certified products include Silodosin,Elagolix sodium,Daprodustat and Vonprazon Fumarate.
Read More
  • Total 4 pages  Go to Page
  • Go
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.

QUICK LINKS

PRODUCT CATEGORY

Copyright © 2023 Shandong Loncom Pharmaceutical Co., Ltd. All Rights Reserved. Sitemap | Privacy Policy
Supported by leadong.com
Contact Us